Diabetic Neuropathy identifies the most accurate early biomarkers of nerve damage to better understand pathophysiology and diagnose diabetic neuropathy in the clinical care of patients, and in particular, permit an accurate evaluation of future therapies in clinical trials. This succinct reference focuses on the current data and research on diabetic neuropathy and is essential reading for researchers in endocrinology, neurology and pharmacology, along with clinicians that need to better understand the novel pathogenetic pathways leading to diabetic neuropathy and the treatments. Serves as a starting point for researchers and medical professionals on risk factors, prevention and newly discovered mechanisms involved in the pathogenesis and eventually treatments of diabetic neuropathy Discusses a broad range of issues relating to diabetic neuropathy, from epidemiology, to pathophysiology, genetics, advances in diagnostic techniques, and the latest clinical trials and clinical management

Diabetic Neuropathy identifies the most accurate early biomarkers of nerve damage to better understand pathophysiology and diagnose diabetic neuropathy in the clinical care of patients, and in particular, permit an accurate evaluation of future therapies in clinical trials. This succinct reference focuses on the current data and research on diabetic neuropathy and is essential reading for researchers in endocrinology, neurology and pharmacology, along with clinicians that need to better understand the novel pathogenetic pathways leading to diabetic neuropathy and the treatments. Serves as a starting point for researchers and medical professionals on risk factors, prevention and newly discovered mechanisms involved in the pathogenesis and eventually treatments of diabetic neuropathy Discusses a broad range of issues relating to diabetic neuropathy, from epidemiology, to pathophysiology, genetics, advances in diagnostic techniques, and the latest clinical trials and clinical management